Derivative Financial Instruments (Details) |
3 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|
|
Oct. 14, 2020
USD ($)
$ / shares
shares
|
Mar. 31, 2021
USD ($)
$ / shares
shares
|
Mar. 31, 2020
USD ($)
|
Dec. 31, 2020
USD ($)
$ / shares
shares
|
Aug. 24, 2020
$ / shares
|
|
| Derivative Financial Instruments | |||||
| Number of units issued | shares | shares | 50,000,000 | 50,000,000 | |||
| Warrant exercise price | $ / shares | $ 11.50 | ||||
| Restriction to transfer sponsor warrants | The Sponsor Warrants (including the Class A common stock issuable upon exercise of the Sponsor Warrants) are not transferable, assignable or salable until 30 days after the completion of the Business Combination and they are non-redeemable so long as they are held by the initial purchasers of the Sponsor Warrants or their permitted transferees. | ||||
| Warrants redemption description | the warrants for redemption: (i) in whole and not in part; (ii) at a price of $0.01 per warrant; (iii) upon not less than 30 days' prior written notice of redemption (the "30-day redemption period") to each warrant holder; and (iv) if, and only if, the reported closing price of the Class A common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders. | ||||
| Warrant exercisable term, after the completion of the Business Combination | 30 days | ||||
| Warrant exercisable term, from the closing of the public offering | 12 months | ||||
| Warrant liability | $ | $ 44,510,000 | $ 55,720,000 | |||
| Change in fair value of warrant derivative liability | $ | $ (11,210,000) | $ 0 | |||
| Public Offering | |||||
| Derivative Financial Instruments | |||||
| Number of units issued | shares | shares | 50,000,000 | 50,000,000 | |||
| Price per unit | $ / shares | $ 10.00 | ||||
| Warrant Convertible Ratio | 0.33 | ||||
| Private placement | |||||
| Derivative Financial Instruments | |||||
| Aggregate warrants | shares | 8,000,000 | ||||
| Warrant exercise price | $ / shares | $ 1.50 | ||||
| Proceeds from warrants outstanding | $ | $ 12,000,000 | ||||
| Class A common stock | |||||
| Derivative Financial Instruments | |||||
| Common stock par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 | $ 0.0001 | ||
| Warrant Convertible Ratio | 1 | ||||
| Class A common stock | Public Offering | |||||
| Derivative Financial Instruments | |||||
| Common stock par value (in dollars per share) | $ / shares | $ 0.0001 | ||||
| Public Warrants | |||||
| Derivative Financial Instruments | |||||
| Aggregate warrants | shares | 16,666,667 | ||||
| Warrant liability | $ | $ 24,830,000 | $ 37,000,000 | |||
| Sponsor Warrants | |||||
| Derivative Financial Instruments | |||||
| Aggregate warrants | shares | 8,000,000 | ||||
| Warrant liability | $ | $ 19,680,000 | $ 18,720,000 | |||